These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6682770)
21. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats. Lee HJ; Paik WH; Lee MG Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911 [TBL] [Abstract][Full Text] [Related]
22. Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion. Speth PA; Linssen PC; Holdrinet RS; Haanen C Clin Pharmacol Ther; 1987 Jun; 41(6):661-5. PubMed ID: 3581649 [TBL] [Abstract][Full Text] [Related]
23. [Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin]. Yayoi E; Furukawa J; Takatsuka Y; Kobayashi T; Aikawa T; Maeura Y; Kaji M; Kotsuma Y Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1621-4. PubMed ID: 1530320 [TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetics of adriamycin by bronchial artery infusion for non-small cell bronchogenic carcinoma]. Wang T; Yang H; Wang H Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):395-8. PubMed ID: 11810771 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model. Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622 [TBL] [Abstract][Full Text] [Related]
26. A natriuretic factor is released by saline infusion into rat renal artery. Bullivant EM; Muñoz DJ Am J Physiol; 1993 Feb; 264(2 Pt 2):R268-80. PubMed ID: 8447483 [TBL] [Abstract][Full Text] [Related]
27. [Analysis of side effects of a combination chemotherapy of cisplatin and adriamycin in gynecological malignancies: comparison between intravenous and intraarterial administration]. Kawagoe K; Tsunoda H; Iijima S; Yokota H; Shigemitsu S Gan To Kagaku Ryoho; 1984 Mar; 11(3):452-7. PubMed ID: 6538404 [TBL] [Abstract][Full Text] [Related]
28. Effects of intravenous infusion of dopamine on tumor blood flow in rat subcutis. Tanda S; Hori K; Saito S; Zhang QH; Li HC; Suzuki M Jpn J Cancer Res; 1994 May; 85(5):556-62. PubMed ID: 8014114 [TBL] [Abstract][Full Text] [Related]
29. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Chen HS; Gross JF Cancer Treat Rep; 1980 Jan; 64(1):31-40. PubMed ID: 6155210 [TBL] [Abstract][Full Text] [Related]
30. [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)]. Majima H; Iguchi H; Tone H Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):542-8. PubMed ID: 3954376 [TBL] [Abstract][Full Text] [Related]
31. A comparison of regional versus systemic drug injection. Adriamycin concentration in peripheral blood and gastric stump (post-Billroth II gastrectomy) in the dog. P'eng FK; Wu CW; Chang TJ; Lui WY Cancer Chemother Pharmacol; 1989; 23(6):363-6. PubMed ID: 2713958 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic analysis of adriamycin (doxorubicin) and related fluorescent compounds in Ehrlich tumor-bearing mouse plasma and tissues. Shinozawa S; Fukuda T; Araki Y; Oda T Acta Med Okayama; 1982 Apr; 36(2):125-32. PubMed ID: 7136849 [TBL] [Abstract][Full Text] [Related]
33. Synergistic combination of YS-1 and adriamycin inhibits human renal cancer through ERK1/2 signaling pathway in vitro and in vivo. Yu X; Yang Q; Lin S; Yuan S; Sun L Oncol Rep; 2017 Mar; 37(3):1756-1764. PubMed ID: 28098907 [TBL] [Abstract][Full Text] [Related]
34. Intra-arterial hepatic chemotherapy with pirarubicin. Preclinical and clinical studies. Rougier P; Munck JN; Elias D; Herait P; Bognel C; Gosse C; Lasser P Am J Clin Oncol; 1990; 13 Suppl 1():S1-4. PubMed ID: 2291452 [TBL] [Abstract][Full Text] [Related]
35. Combination therapy with adriamycin and interleukin 2 augments immunity against murine renal cell carcinoma. Gautam SC; Chikkala NF; Ganapathi R; Hamilton TA Cancer Res; 1991 Nov; 51(22):6133-7. PubMed ID: 1682042 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours. Lee HJ; Lee MG Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889 [TBL] [Abstract][Full Text] [Related]
37. [Selective hepatic arterial infusion of liposomes containing antitumor agents]. Kumai K; Takahashi T; Tsubouchi T; Yoshino K; Ishibiki K; Abe O Gan To Kagaku Ryoho; 1985 Oct; 12(10):1946-8. PubMed ID: 4051510 [TBL] [Abstract][Full Text] [Related]
38. [Studies on pharmacologic disposition of adriamycin in dog after hepatic arterial embolization with adriamycin carboxymethyl-dextran-microspheres]. He SM; Sun YC; Wei SL; Wu CB; Wang PU; Wang SD; Xie JX Yao Xue Xue Bao; 1993; 28(11):859-64. PubMed ID: 7516606 [TBL] [Abstract][Full Text] [Related]
39. Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients. Speth PA; Linssen PC; Boezeman JB; Wessels HM; Haanen C Cancer Chemother Pharmacol; 1987; 20(4):305-10. PubMed ID: 3480081 [TBL] [Abstract][Full Text] [Related]